23976111000001109: Vitekta 150mg tablets (Gilead Sciences Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Vitekta 150mg tablets (Gilead Sciences Ltd)
\UK product\Virtual medicinal product\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\UK product\Virtual therapeutic moiety\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\UK product\Trade family\Vitekta\Vitekta 150mg tablets (Gilead Sciences Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing nucleotidyltransferase inhibitor\Product containing integrase strand transfer inhibitor\Product containing elvitegravir\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing elvitegravir\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing chlorine and/or chlorine compound (product)\Product containing chlorinated hydrocarbon\Product containing elvitegravir\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Product containing elvitegravir\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing halogenated hydrocarbon\Product containing chlorinated hydrocarbon\Product containing elvitegravir\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing elvitegravir\Elvitegravir\Elvitegravir 150mg tablets\Vitekta 150mg tablets (Gilead Sciences Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1840821000001113 Vitekta 150mg tablets (Gilead Sciences Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1840841000001115 Vitekta 150mg tablets (Gilead Sciences Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Is a	Elvitegravir 150mg tablets	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has specific active ingredient	Elvitegravir	false	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Is a	Vitekta	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has active ingredient	Substance with antiviral mechanism of action	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has specific active ingredient	Elvitegravir	true	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Vitekta 150mg tablets (Gilead Sciences Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Vitekta 150mg tablets (Gilead Sciences Ltd) 30 tablet	Has AMP	True	Vitekta 150mg tablets (Gilead Sciences Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1840821000001113	Vitekta 150mg tablets (Gilead Sciences Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1840841000001115	Vitekta 150mg tablets (Gilead Sciences Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module